Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2281-2295
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2281
Figure 2
Figure 2 Evaluate reliability and accuracy of risk signature. A and B: The dispersion of patients' survival conditions and risk scores revealed that as the risk score rose, more people died; C: Nine pyroptosis-related long non-coding RNAs' expression heatmap between high-risk group and low-risk group; D: Age, sex, clinical stage, distant metastasis, lymph node metastasis, and tumor size had lower reliability than the risk signature; E: By doing a 1-, 2-, and 3-year receiver operating characteristic analysis, the prognostic utility of the risk signature was confirmed; F: Decision curve analysis was used to assess the dependability of the risk signature.